Airsculpt Technologies, Inc. (AIRS) stock
AIRSNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 4/3084% below fair value
$0.74+0.04 (+5.53%)
Close on Nov 17, 2026Market cap $53.26MP/E –Yield –
Airsculpt Technologies r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Airsculpt Technologies
Airsculpt Technologies has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?